Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: Changes in pulmonary hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 619-624

  Maclean, M R ^a   Johnston, E D ^a   Mcculloch, K M ^a   Pooley, L ^a   Houslay, M D ^a   Sweeney, G ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; PHOSPHODIESTERASE; ZAPRINAST;

ANIMAL CELL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME SPECIFICITY; HYPOXIA; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

ANIMALS; HYPERTENSION, PULMONARY; ISOENZYMES; MALE; PHOSPHORIC DIESTER HYDROLASES; PULMONARY ARTERY; PURINONES; RATS; RATS, WISTAR;

EID: 0030733082     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. BANNER, K. H. AND PAGE, C. P.: Theophylline and selective phosphodiesterase inhibitors as antiinflammatory drugs in the treatment of bronchial asthma. Eur. Resp. J. 66: 996-1000, 1995.
2. BEAVO J. A.: Cyclic nucleotide phosphodiesterases - functional implications of multiple isoforms. Physiol. Rev. 75: 725-748, 1995.
3. BENTLEY, J. K. AND BEAVO, J. A.: Regulation and function of cyclic nucleotides. Curr. Opin. Cell Biol. 4: 233-240, 1992.
4. BOLGER, G.: Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: A diverse family of regulatory enzymes. Cellular Signalling 6: 851-859, 1994.
5. BRANER, D. A., FINEMAN, J. R., CHANG, R. AND SOIFER, S. J.: M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am. J. Physiol. 264: H252-H258, 1993.
6. CHRISTENSEN, S. B. AND TORPHY, T. J.: Isozyme-selective phosphodiesterase inhibitors as antiasthmatic agents. Ann. Rep. Med. Chem. 29: 185-194, 1994.
7. CLARKE, W. R., UEZONA, S., VILLACRES, E. C. AND STORM, D. R.: The type-III phosphodiesterase inhibitor milrinone and type-V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance. Pulm. Pharmacol. 7: 81-89, 1994.
8. CORTIJO, J., Bou, J., BELETA, J., CARDEL'US, I., LLENAS, J., MORCILLO, E. AND GRISTWOOD, R. W.: Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br. J. Pharmacol. 108: 562-568, 1993.
9. CREMONA, G., WOOD, A. M., HALL, L. W., BOWER, E. A. AND HIGENBOTTAM, T.: Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J. Physiol. 481: 185-195, 1994.
10. ERDOGAN, S. AND HOUSLAY, M. D.: Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J. 321: 165-175, 1997.
11. FULLE, H. J. AND GARBERS, D. L.: Guanylyl cyclases - a family of receptor-linked enzymes. Cell Biochem. Function 12: 157-165, 1994.
12. GIAID, A. AND SALEH, D.: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. New Eng. J. Med. 333: 214-221, 1995.
13. GIEMBYCZ, M. A.: Phosphodiesterase 4 and tolerance to beta (2)-adrenoceptor agonists in asthma. Trends Pharmacol. Sci. 17: 331-336, 1996.
14. GILLESPIE, P. G. AND BEAVO, J. A.: Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22948. Mol. Pharmacol. 36: 773-781, 1989.
15. HEATH, C., EDWARDS, M., WINSON, M AND SMITH, P.: Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax 28: 24-28, 1973.
16. HERGET, J., SUGGETT, A. J., LEACH, E. AND BARER, G. R.: Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia. Thorax 33: 468-473, 1978.
17. ICHINOSE, F., ADRIE, C., HURFORD, W. E. AND ZAPOL, W. R.: Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J. Appl. Physiol. 78: 1288-1295, 1995.
18. ISAACSON, T. C., HAMPL, V., WEIR, E. K., NELSON, D. P. AND ARCHER, S. L.: Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
19. LEVITZKI, A.: Targeting signal transduction for disease therapy. Curr. Opin. Cell Biol. 8: 239-244, 1996.
20. 1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: Influences of vascular endothelium and tone. Pulm. Pharmacol. 7: 65-72, 1994a.
21. B receptor mediated vasoconstriction in rat pulmonary artery and arterioles. J. Cardiovasc. Pharmacol. 23: 838-845, 1994b.
22. MACLEAN, M. R., MCCULLOCH, K. M. AND BAIRD, M.: Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C and on inherent tone in rat pulmonary arteries. J. Cardiovasc. Pharmacol. 26: 822-830, 1995.
23. MACLEAN, M. R., SWEENEY, G., BAIRD, M., MCCULLOCH, K. M., HOUSLAY, M. AND MORECROFT, I.: 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br. J. Pharmacol. 119: 917-930, 1996.
24. MANGANIELLO, V. C., MURATA, T., TAIRA, M., BELFRAGE, P. AND DEGERMAN, E.: Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophy. 322: 1-13, 1995a.
25. MANGANIELLO, V. C., TAIRA, M., DEGERMAN, E. AND BELFRAGE, P.: Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell. Sig. 7: 445-455, 1995b.
26. MANI, S. AND SMITH, G. J. W.: HIV and pulmonary hypertension - a review. Southern Med. J. 87: 357-362, 1994.
27. MARCHMONT, R. J. AND HOUSLAY, M. D.: A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem. J. 187: 381-392, 1980.
28. MICHIE, A. M., LOBBAN, M., HARNETT, M. M. AND HOUSLAY, M. D.: Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T-cell antigen receptor on thymocytes - analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Cell. Sig. 8: 97-110, 1996.
29. PODZUWEIT, T., NENNSTIEL, P. AND MULLER, A.: Isozyme-selective inhibition of cGMP-stimulated cyclic-nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell. Sig. 7: 733-738, 1995.
30. POLSON, J. B. AND STRADA, S. J.: Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 36: 403-427, 1996.
31. RABE, K. F., TENOR, H., DENT, G., SCHUDT, C., NAKASHIMA, M. AND MAGNUSSEN, H.: Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am. J. Physiol. 266: L536-L543, 1994.
32. RODMAN, D. M., YAMAGUCHI, T., HASUNUMA, K., O'BRIEN, R. F. AND MCMURTRY, I. F.: Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery. Am. J. Physiol. 250: L207-214, 1990.
33. SASAKI, S. I., KOBAYASHI, N., DAMBARA, T., KIRA, S. AND SAKAI, T.: Structural organization of pulmonary arteries in the rat lung. Anat. Embryol. 191: 477-489, 1995.
34. SCOTT, J. D.: Cyclic nucleotide-dependent protein kinases. Pharmacol. Ther. 50: 123-145, 1991.
35. SHAUL, P. W., WELLS, L. B. AND HORNING, K. M.: Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J. Cardiovasc. Pharmacol. 22: 819-827, 1993.
36. SHEEDY, W., THOMPSON, J. S. AND MORICE, A. H.: A comparison of pathophysiological changes during hypobaric and normobaric hypoxia in rats. Resp. 63: 217-222, 1996.
37. SPENCE, S., RENA, G., SWEENEY, G. AND HOUSLAY, M. D.: Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms. Biochem. J. 310: 975-982, 1995.
38. SUNAHARA, R. K., DESSAUER, C. W. AND GILMAN, A. G.: Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol. 36: 461-480, 1996.
39. SWEENEY, G., TEMPLETON, A., CLAYTON, R. A., BAIRD, M., SHERIDAN, S., JOHNSTON, E. D. AND MACLEAN, M. R.: Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: Relationship to tone and cyclic nucleotide levels. J. Cardiovasc. Pharmacol. 26: 751-760, 1995.
40. 4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br. J. Pharmacol. 118: 1727-1735, 1996.
41. THOMPSON, W. J. AND APPLEMAN, M. M.: Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10: 311-316, 1971.
42. THUSU, K. G., MORIN, F. C., RUSELL, J. A. AND STEINHORN, R. H.: The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am. J. Resp. Crit. Care Med. 152: 1605-1610, 1995.
43. TORPHY, T. J.: β-Adrenoceptors, cAMP and airway smooth muscle relaxation - challenges to the dogma. Trends Pharmacol. Sci. 15: 370-374, 1994.
44. TRELL, E.: Pulmonary hypertension in disorders of the left heart. Observations on catheterisation material. Scand. J. Clin. Lab. Invest. 31: 409-418, 1973.
45. VENDER, R. L.: Chronic hypoxic pulmonary hypertension - cell biology to pathophysiology. Chest 106: 236-243, 1994.
46. WANSTALL, J. C., O'DONNELL, S. R. AND KAY, C. S.: Increased relaxation by felodipine on pulmonary artery from rats with monocrotaline-induced pulmonary hypertension does not reflect functional impairment of the endothelium. Pulmonary Pharmacol. 4: 60-66, 1991.
47. XUE, C., RENGASAMY, A., LE CRAS, T. D., KOBERNA, P. A., DAILEY, C. AND JOHNS, R. A.: Distribution of NOS in normoxic vs. hypoxic rat lung: Upregulation of NOS by chronic hypoxia. Am. J. Physiol. 267: L667-L678, 1994.